Asthma Clinical Trials in Phoenix

Showing 161-169 of 169 trials

A Pilot Study Involving an Asthma Management Program for Inner-city Early Head Start Children

NCT00624429

The Early Head Start program serves lower socioeconomic inner-city children from birth to 3 years. This population has a higher incidence of asthma due to increased exposures. The primary objective of this study is: To evaluate the effect of early identification of these high risk, inner-city asthmatic infants, age 1-3 years, and early treatment with pulmicort respules on asthma morbidity (asthma symptoms and use of rescue medications), infant pulmonary functions, and use of health care resources (unscheduled clinic visits, emergency room visits and hospitalizations). To obtain pilot behavior information using Carey Temperament Scale, Bitsea and expand to Itsea if indicated.

Asthma

Phoenix Children's Hospital20 participantsStarted Mar 2008

Phoenix, Arizona, United States

COMPLETEDPHASE411 miles

Evaluate the Effect of Omalizumab on Markers of Asthma Impairment in Patients With Persistent Allergic Asthma

NCT00870584

This study will evaluate the effect of omalizumab on markers of impairment in patients with inadequately controlled persistent allergic asthma on Step 4 or above therapy as defined in the 2007 National Heart, Lung, and Blood Institute (NHBLI) Guidelines

Persistent Allergic Asthma

Novartis Pharmaceuticals271 participantsStarted Mar 2009

Jasper, Alabama, United States • Anchorage, Alaska, United States • Scottsdale, Arizona, United States +47 more locations

A Pilot Study Involving an Asthma Management Program for Inner-city Early Head Start Children

Evaluate the Effect of Omalizumab on Markers of Asthma Impairment in Patients With Persistent Allergic Asthma

Asthma Trials in Other Cities

Efficacy, Safety and Pharmacokinetics of Different Regimens of Indacaterol

A Two-week Study Assessing the Onset of Effect Questionnaire (OEQ) Administered Daily Versus Weekly in Adult Subjects

Pilot Study in Patients With Symptomatic Steroid-Naive Asthma

Reliability of a Top Mount Actuation Indicator With Levalbuterol MDI in Adult and Pediatric Subjects With Asthma or COPD

Safety and Tolerability Study of Levalbuterol HFA Compared to Racemic Albuterol HFA in Subjects With Asthma

Study to Evaluate the Human Infection of the Lower Respiratory Tract in Children at High Risk

The Oscillation for ARDS Treated Early (OSCILLATE) Trial Pilot Study

Other Conditions in Phoenix